Treatment-resistant psychotic symptoms and early-onset dementia: A case report of the 3q29 deletion syndrome
暂无分享,去创建一个
P. Sullivan | J. Berg | J. Crowley | J. Szatkiewicz | M. Farrell | R. Josiassen | R. Stowe | G. Lázaro-Muñoz | Dawn M. Filmyer | Tyler E. Dietterich | R. Shaughnessy | M. Lichtenstein | Matthew K. Harner | Lisa M. Bruno | Tamara F. Biondi
[1] Darlyne G. Nemeth,et al. Understanding the neuropsychological effects of 3q29 deletion Syndrome: A fraternal twin case study , 2020, Applied neuropsychology. Child.
[2] E. Walker,et al. Comprehensive phenotyping of neuropsychiatric traits in a multiplex 3q29 deletion family: a case report , 2020, BMC Psychiatry.
[3] P. Sullivan,et al. Treatment-resistant psychotic symptoms and the 15q11.2 BP1–BP2 (Burnside-Butler) deletion syndrome: case report and review of the literature , 2020, Translational Psychiatry.
[4] Anna Frengen,et al. Neuropsychiatric phenotype in relation to gene variants in the hemizygous allele in 3q29 deletion carriers: A case series , 2019, Molecular genetics & genomic medicine.
[5] M. Epstein,et al. Neuropsychiatric phenotypes and a distinct constellation of ASD features in 3q29 deletion syndrome: results from the 3q29 registry , 2019, Molecular Autism.
[6] M. Puiu,et al. A Novel 3q29 Deletion in Association With Developmental Delay and Heart Malformation—Case Report With Literature Review , 2019, Front. Pediatr..
[7] Wahab A. Khan,et al. Familial inheritance of the 3q29 microdeletion syndrome: case report and review , 2019, BMC Medical Genomics.
[8] J. Rosenfeld,et al. Novel features of 3q29 deletion syndrome: Results from the 3q29 registry , 2016, American journal of medical genetics. Part A.
[9] M. Butler,et al. A clinical case report and literature review of the 3q29 microdeletion syndrome , 2015, Clinical dysmorphology.
[10] J. Mulle. The 3q29 deletion confers >40-fold increase in risk for schizophrenia , 2015, Molecular Psychiatry.
[11] Stephen J. Guter,et al. Co‐occurrence of autism, childhood psychosis, and intellectual disability associated with a de novo 3q29 microdeletion , 2013, American journal of medical genetics. Part A.
[12] R. Deshaies,et al. NEDD8 links Cullin–Ring ubiquitin Ligase function to the p97 pathway , 2012, Nature Structural &Molecular Biology.
[13] S. Leib,et al. Association of kynurenine aminotransferase II gene C401T polymorphism with immune response in patients with meningitis , 2011, BMC Medical Genetics.
[14] J. Cummings,et al. The Montreal Cognitive Assessment, MoCA: A Brief Screening Tool For Mild Cognitive Impairment , 2005, Journal of the American Geriatrics Society.
[15] S. Folstein,et al. “Mini-mental state”: A practical method for grading the cognitive state of patients for the clinician , 1975 .
[16] Charles D. Smith,et al. APOE is a potential modifier gene in an autosomal dominant form of frontotemporal dementia (IBMPFD) , 2007, Genetics in Medicine.
[17] D. Wechsler. WAIS-R manual : Wechsler adult intelligence scale-revised , 1981 .